Language is one of several barriers to inclusivity in clinical trials. In this Vistatec webinar, Citeline’s Lya Rebelo joins panelists in discussing ways to address this challenge.

I feel that even if formal mandates shift, the scientific, ethical, and commercial imperative for inclusive trials remains strong.
Lya Rebelo, Commercial Enablement Manager, Citeline

Related resources

A female scientist in a lab coat holds a tube, conducting experiments in a laboratory setting.
MAY 07, 2024
Article
Clinical

Diversity at the Start: Best Practices for Clinical Trial Planning

Study sponsors should begin their clinical trial diversity efforts with a fit-for-purpose clinical protocol.

White paper cover for Practical Strategies for Ensuring a Diverse Patient Population in Clinical Trials
OCT 25, 2024
Whitepaper
Clinical

臨床試験における多様な患者集団を確保するための実践的戦略

臨床試験はますます複雑化しています。1試験あたりのエンドポイント数、手順数、実施施設数はいずれも増加しています。これにより、患者募集、特に多様な患者層の募集がより困難になっています。Citelineの専門家が、こうした募集上の課題を克服するためのヒントを共有します。

global diversity-resource-card-thumbnail
NOV 06, 2023
Article
Clinical

Clinical Trial Diversity on a Global Scale

Reporting clinical trial racial and ethnic data is a crucial step toward clinical trial diversity. But these definitions can be different across countries.